Short-Term Administration of Serelaxin Produces Predominantly Vascular Benefits in the Angiotensin II/L-NAME Chronic Heart Failure Model

In patients hospitalized with acute heart failure, temporary serelaxin infusion reduced 6-month mortality through unknown mechanisms. This study therefore explored the cardiovascular effects of temporary serelaxin administration in mice subjected to the angiotensin II (AngII)/L-NG-nitroarginine meth...

Descripción completa

Detalles Bibliográficos
Autores principales: McCarthy, Joseph C., Aronovitz, Mark, DuPont, Jennifer J., Calamaras, Timothy D., Jaffe, Iris Z., Blanton, Robert M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
PRECLINICAL RESEARCH
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034497/
https://www.ncbi.nlm.nih.gov/pubmed/30062150
http://dx.doi.org/10.1016/j.jacbts.2017.03.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034497/
https://www.ncbi.nlm.nih.gov/pubmed/30062150
http://dx.doi.org/10.1016/j.jacbts.2017.03.011

Ejemplares similares